Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01475565 · ClinicalTrials.gov registry record

Insulin Resistance Before and During Pregnancy in Women With Polycystic Ovary Syndrome

A clinical trial, sponsored by Virginia Commonwealth University.

Terminated
Registry status
2
Enrollment target

NCT01475565: Clinical Trial study, sponsored by Virginia Commonwealth University.

NCT01475565 is a clinical trial that was terminated before completion, run by Virginia Commonwealth University. The registered enrollment target is 2 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01475565 was terminated before completion, sponsored by Virginia Commonwealth University.

TERMINATED
Registry status
2 participants
Enrollment target

Study Summary

The polycystic ovary syndrome (PCOS) affects about 10% of reproductive-age women. Women with PCOS are at a higher risk of gestational diabetes, which may lead to more pregnancy complications. It is unknown if there are factors that may predict which women are more at risk. The goal of this study is to evaluate the risk factors of gestational diabetes, such as dietary and physical activity factors, race, and how the body handles its own hormones during pregnancy. Our long term goal is to contribute in finding ways to successfully prevent gestational diabetes.

Trial Details

FieldValue
Enrollment Target 2 participants
Start Date 2013-05
Est. Completion 2014-08
Virginia Commonwealth University

558 total trials

Why NCT01475565 stopped before completion

NCT01475565 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 2 participants, a relatively small participant target.

The record links to 0 conditions, and to 0 interventions.

NCT01475565 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01475565 about?

NCT01475565 is a clinical study titled "Insulin Resistance Before and During Pregnancy in Women With Polycystic Ovary Syndrome". The polycystic ovary syndrome (PCOS) affects about 10% of reproductive-age women. Women with PCOS are at a higher risk of gestational diabetes, which may lead to more pregnancy complications. It is unknown if there are factors that may predict which women are more at risk. The goal of this study is...

What is the current status of trial NCT01475565?

This trial is currently terminated. The enrollment target is 2 participants. The study started on 2013-05. Estimated completion is 2014-08.

Who is sponsoring clinical trial NCT01475565?

This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01475565, the US trial registry maintained by the National Library of Medicine. NCT01475565 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.